Navigation Links
Hemostemix Meets with Newly Formed Clinical Trial Steering Committee
Date:12/20/2013

Toronto, Ontario (PRWEB) December 20, 2013

Hemostemix Ltd. announced today the formation and inaugural meeting of a clinical trial steering committee to guide the company in optimizing all aspects of the upcoming Phase 2 trial for its lead product, ACP-01, in patients with critical limb ischemia.

As well-respected specialists in critical limb ischemia and vascular surgery, the role of the Clinical Trial Steering Committee will be to advise the Company on all matters critical to the trial’s success.

“We are extremely honored with the caliber of key opinion leaders who have committed to providing us with their expertise on the trial’s design, implementation, sites, enrollment criteria, and several other critical parameters,” stated Hemostemix Founder and President, Dr. Valentin Fulga.

“We believe we have a real opportunity to learn valuable lessons from the committee’s collective experience in the space and translate that into a successful trial. The committee is providing valuable input in this regard,” continues Dr. Fulga, “and we were pleased to have what proved to be a very valuable inaugural meeting this week in Toronto.”

The committee is comprised of prominent clinician scientists, namely:

  •     Mohammed Al-Omran, MD is Professor of Surgery at University of Toronto and King Saud University and Chief of Vascular Surgery Division at St Michael’s Hospital. Dr. Al-Omran is a clinician investigator and currently appointed as a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. His research interests are focused on atherosclerosis bench to bedside with special interest in peripheral arterial disease.
  •     Elmar R. Burchardt, MD, PhD, DS., is Professor of Clinical Pharmacology at the Univers
    '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Hemostemix Hosts Cell Therapy Industry Seminar
2. Hemostemix Announces Formation of Scientific Advisory Board
3. Hemostemix Announces US Patent Allowance
4. The Hemostemix Group of Companies Provides Corporate Strategy Update
5. What can happen when graphene meets a semiconductor
6. Discovery Meets Recovery in New Cedars-Sinai’s Advanced Health Sciences Pavilion Designed by HOK
7. Marken Meets Critical Demand For In Vitro Lab Shipments
8. SPIE ‘gold’ open access program meets new needs of UK authors -- and others
9. Origami meets chemistry in scholarly video-article
10. Veridiams Training Program Wins Accolades and Awards- Meets Skilled Labor Challenge Head On
11. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 Earle ... LLC, announced today that Ellen Teplitzky, an experienced ... for the pharmaceutical industry, has joined the firm ... its legal services practice. NDA Partners provides ... witness and testimony, to top law firms and ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report defines and ... and forecast of revenue. , Browse through the ... to get an idea of the in-depth analysis ... segmentation in the Asia-Pacific bromine market, and is ... http://www.micromarketmonitor.com/market/asia-pacific-bromine-6741503144.html , Bromine is a volatile ...
(Date:10/19/2014)... October 19, 2014 The report ... & Homeland Security), Technology, Payload, Type & by ... segments the global unmanned ground vehicle market into ... forecasting of market sizes. The report also identifies ... opportunities impacting it along with the adoption trends. ...
(Date:10/18/2014)... The Asian arthroscopic devices report defines and ... forecast of revenue. The arthroscopic devices market in Asia ... at a CAGR of 6.5% from 2013 to 2018. ... devices market, to get an idea of the in-depth ... segmentation of arthroscopic devices market in the same region, ...
Breaking Biology Technology:NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 2Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 3Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 4Unmanned Ground Vehicle (UGV) Market Estimated to Reach $8.26 Billion by 2020 - New Research Report by MarketsandMarkets 5The Asian arthroscopic devices market is estimated to grow to $712.3 million by 2018 - New Report by MicroMarket Monitor 2The Asian arthroscopic devices market is estimated to grow to $712.3 million by 2018 - New Report by MicroMarket Monitor 3The Asian arthroscopic devices market is estimated to grow to $712.3 million by 2018 - New Report by MicroMarket Monitor 4
... EntreMed, Inc. (Nasdaq: ENMD ), a ... cancer today announced the presentation of clinical data for ... cancer patients.   The data were presented by the ... medical director of gynecologic oncology at Dana-Farber Cancer Institute ...
... LifeVantage Corporation (OTCBB: LFVN), the maker of ... reduction of oxidative stress by the synergistic activation ... review article involving Protandim® was published in the ... (Logo:   http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO ) ...
... Houston researchers have developed a method for creating single-crystal ... the possibility of a replacement for silicon in high-performance ... their collaborators is featured on the cover of the ... a one-atom-thick layer of carbon that was first fabricated ...
Cached Biology Technology:EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 2EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 3EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 4LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 3LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 4LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 5University of Houston develops method for creating single-crystal arrays of graphene 2
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
(Date:10/15/2014)... pandemic risk from strains of influenza virus increases with ... to become complacent that the most substantial threats have ... Influenza pandemics arise when a new virus strain – ... – spreads in the human population. There have been ... worst of which – the 1918 Spanish Flu – ...
(Date:10/15/2014)... in female mice to an enzyme activated by the ... resistant to respiratory infections than males. Now, an international ... bacterial pneumonia in female mice is linked to the ... that this enzyme is ultimately activated by the release ... lead by Professor Lester Kobzik at the Harvard University ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
... , This release is available in German ... and spokesman for Solar Energy Research at Helmholtz-Zentrum Berlin (HZB), ... Solar Energy Conference and Exhibition" in Valencia. The EU Commission ... field of photovoltaics. The award ceremony took place ...
... Pine trees, scientists have shown that the iconic pine forests ... that colonised Britain after the end of the last Ice ... according to new results published in the journal Heredity ... team from the Centre for Ecology & Hydrology, the Polish ...
... Cotton growers can produce more cotton if they ... of an article published in the September-October 2010 ... of Agronomy. Bill Pettigrew, a scientist with the ... of cotton under irrigated and non-irrigated plots, with half ...
Cached Biology News:Untiring dedication to solar energy 2Scots Pine shows its continental roots 2Early cotton planting requires irrigation 2
...
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454...
Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
Human Regulatory T cell Staining Kit #2 (w/ APC Foxp3 PCH101, FITC CD4, PE CD25)...
Biology Products: